Related Experiment Video

Updated: Aug 18, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

[HDL-cholesterol--active or passive participant in the pathogenesis of atherosclerosis? (II)]

Anca Artenie1, R Artenie, Didona Ungureanu

  • 1Spitalul Clinic C.I. Parhon Iaşi, Clinica a IV-a Medicală.

Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
|April 19, 2005
PubMed

Insights

High cholesterol and LDL-cholesterol contribute to atherosclerosis. Statins and fibrates effectively lower these levels and increase HDL-cholesterol, aiding atherosclerosis regression.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Context:

  • Atherosclerosis is a significant health concern linked to elevated cholesterol and LDL-cholesterol.
  • Current treatments for hypercholesterolemia include statins and fibrates.

Purpose:

  • To review the mechanisms by which statins and fibrates increase HDL-cholesterol.
  • To correlate these mechanisms with the regression of atherosclerosis.

Summary:

  • High cholesterol and LDL-cholesterol are key factors in atherosclerosis development.
  • Statins and fibrates effectively reduce cholesterol and LDL-cholesterol levels.
  • These therapies also increase HDL-cholesterol, which plays a crucial role in atherosclerosis regression.

Impact:

  • Understanding HDL-cholesterol elevation mechanisms can optimize lipid-lowering therapies.
  • This knowledge may lead to improved management strategies for cardiovascular disease.
  • Enhanced HDL-cholesterol levels are associated with reduced atherosclerotic burden.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...